期刊文献+

子宫内膜异位症腹腔镜保守手术后不同延续用药治疗的临床观察 被引量:7

Clinical observation of different drugs in treatment of endometriosis after laparoscopy operation
原文传递
导出
摘要 目的:探讨子宫内膜异位症腹腔镜保守手术后不同延续用药对预后的影响。方法:腹腔镜下子宫内膜异位症保守手术的Ⅲ期、Ⅳ期子宫内膜异位症患者160例。其中A组43例,术后不用药;B组53例,术后加用促性腺激素释放激素激动剂(GnRH-a)治疗(曲普瑞林);C组64例,术后加用短效避孕药炔雌醇环丙孕酮(达英-35)。比较3组患者术后症状缓解率、复发率及受孕率。结果:3组的术后2年症状缓解率无统计学差异(P>0.05);B、C组的复发率低于A组(P<0.05),B组的复发率低于C组(P<0.05);B、C组的受孕率高于A组(P<0.05)。结论:中重度子宫内膜异位症腹腔镜手术治疗后加用曲普瑞林或达英-35巩固治疗,能降低复发率并提高受孕率,且曲普瑞林的疗效优于达英-35。 Objective:To explore the effect of different continure medication on prognosis after laparoscope conservative operation of endometriosis.Methods:The postoperative women were divided into 3 groups:35 without endocrinal therapy(group A),43 treated with gonadotropin releasing hormone agonist(GnRH-a)(3.75 mg,once every 28 d,group B),51 treated with Diane-35(1 tablets every day,group C).The remission rate,recurrent rate and incidence of adverse drug reactions were compared.Results:The postoperational 2 year symptom alleviation rate among 3 groups had no significance(P0.05).The recurrence rate of Group B and C was lower than that in Group A(P0.05),but that of Group B was lower than that of Group C(P0.05),the conception rate of Group B and C was higher than that of Group A(P0.05).Conclusion:Laparoscope conservative postoperation combined triptorelin or Diane-35 in moderate and severe endometriosis could consolidate therapeutic effect,reduce recurrent and conception rate,and triptorelin has the better effect than Diane-35.
出处 《中国妇幼保健》 CAS 北大核心 2011年第19期2912-2914,共3页 Maternal and Child Health Care of China
关键词 子宫内膜异位症 腹腔镜保守手术 曲普瑞林 炔雌醇环丙孕酮 Endometriosis Laparoscopy Gonadotropin releasing hormone agonist Diane-35
  • 相关文献

参考文献1

二级参考文献1

  • 1范螂娣.卵巢临床与病理[M].天津:天津科学技术出版社,1993.97.

共引文献20

同被引文献60

  • 1李雅琪,杨炜婷,彭俊,宋致蓉,廖国芳,张瑜,马燕,罗连英.曲普瑞林治疗多囊卵巢综合征不孕的疗效观察[J].现代预防医学,2012,39(22):5825-5826. 被引量:2
  • 2黄作香,徐博.腹腔镜手术联合米非司酮治疗子宫内膜异位症46例临床分析[J].中国妇幼保健,2007,22(25):3507-3508. 被引量:15
  • 3Berkes E, Bokor A, Rigo J J. [Current treatment of endometriosis with laparoscopic surgery [J]. Orv Hetil, 2010; 151(28 ) : 1137-1144.
  • 4刘霞,张红霞,王丽萍,等.不同剂量长效曲普瑞林在子宫内膜异位症术后治疗中的应用[C].中国福建厦门:2012.
  • 5Takeuchi H,Kobori H, Kikuchi I, et al. A prospec- tive randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis [J]. J Obstet Gynaecol Res, 2000; 26(5 ) : 325-331.
  • 6Olive D L. Optimizing gonadotropin-releasing hor- mone agonist therapy in women with endometriosis [J]. Treat Endocrinol, 2004; 3 ( 2 ) : 83-89.
  • 7FERRERO S, LEONE ROBERTI MAGGIORE U,SCALA C, et al. Changes in the size of rectovaginal endometriotic nodules infiltra- ting the rectum during hormonal therapies [ J ]. Arch Gynecol Ob- stet,2013,257(3) :447 -453.
  • 8FATIMA P, HOSSAIN MM, RAHMAN D, et al. Outcome of preg- nancies after inadvertent exposure to GnRH agonist in early preg- nancy [ J ]. Mymensingh Med J,2011,20 (2) :303 - 307.
  • 9江世敏.米非司酮与孕三矽统用于子宫内膜异位症术后的对比研究[J].临床合理用药,2011,18(3):46.
  • 10Ferrero S,Camerini G,Seracchioli R,et al.Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis[J].Human Reproduction,2009,24(12):3033-3041.

引证文献7

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部